News
OSLO, Norway--(BUSINESS WIRE)--OncoImmunity has become the first company to obtain a CE-IVD mark for the clinical use of a machine-learning based neoantigen prediction technology. This quality ...
DUBLIN--(BUSINESS WIRE)--The "IVD Test Procedure Volumes, 2019-2024" report has been added to ResearchAndMarkets.com's offering. In vitro diagnostic (IVD) test volumes are the gold standard for ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback